http://www.zibb.com/all/theme/cq/Cell+Genesys+Incorporated Zibb. The Global business search engine. en-US search@zibb.com (RB Search)Copyright (c) 2007 Reed Business Information. All rights reserved.Thu, 29 Oct 2009 21:02:59 GMTThu, 29 Oct 2009 21:02:59 GMT608831http://www.zibb.com/all/theme/cq/Cell+Genesys+Incorporated http://www.zibb.com/images/en/g_zibb_logo_beta.gif http://www.zibb.com/article/5630277/Cell+Genesys+Inc+CEGE+Corporate+Event+Announcement+NoticeCell Genesys Inc (CEGE) Expected next earnings release: Announcement date: 11/5/2009 - After Market Earnings Quarter: Q3 Announcement Status: Unconfirmedhttp://www.zibb.com/article/5630277/Cell+Genesys+Inc+CEGE+Corporate+Event+Announcement+NoticeCell Genesys IncorporatedThu, 29 Oct 2009 21:02:59 GMThttp://seekingalpha.com/article/167782-transformative-times-for-biosante-pharmaceuticals?source=feed"The last 75 days have been transformative for BioSante," Bill Milling, Sr. Dir Operations for BioSante Pharmaceuticals, Inc. (BPAX) told BioMedReports. Yesterday, the company announced positive safety data in its ongoing LibiGel Phase III clinical development program.http://seekingalpha.com/article/167782-transformative-times-for-biosante-pharmaceuticals?source=feedCell Genesys IncorporatedWed, 21 Oct 2009 05:09:08 GMThttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=8499BioSante Pharmaceuticals, Inc. (NASDAQ:BPAX) and Cell Genesys, Inc. (NASDAQ:CEGE), today announced the successful completion of their previously announced merger of Cell Genesys with and into BioSante, with BioSante ashttp://www.pharmiweb.com/pressreleases/pressrel.asp?ROW_ID=8499Cell Genesys IncorporatedThu, 15 Oct 2009 01:00:00 GMThttp://rdmag.com/News/FeedsAP/2009/10/life-sciences-biosante-completes-cell-genesys-buyout/BioSante-Cell Genesys to focus on developing therapy to treat female sexual dysfunctionhttp://rdmag.com/News/FeedsAP/2009/10/life-sciences-biosante-completes-cell-genesys-buyout/Cell Genesys IncorporatedWed, 14 Oct 2009 19:25:36 GMThttp://sanfrancisco.bizjournals.com/sanfrancisco/stories/2009/10/12/daily47.html?ana=from_rssshareholders overwhelmingly approved the company’s $38 million stock merger Wednesday with BioSante Pharmaceuticals Inc., two weeks after the company couldn’t garner enough votes in favor of the deal.http://sanfrancisco.bizjournals.com/sanfrancisco/stories/2009/10/12/daily47.html?ana=from_rssCell Genesys IncorporatedWed, 14 Oct 2009 19:08:37 GMThttp://www.biospace.com/news_story.aspx?StoryID=154898&full=1LINCOLNSHIRE, Ill. & SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) and Cell Genesys, Inc. (NASDAQ: CEGE), today announced that each will hold a special stockholders meeting on September 30, 2009 at which time stockholders will be asked to approve thehttp://www.biospace.com/news_story.aspx?StoryID=154898&full=1Cell Genesys IncorporatedThu, 03 Sep 2009 12:00:00 GMThttp://nanotechwire.com/news.asp?nid=8151BioSante Pharmaceuticals, Inc. and Cell Genesys, today announced that they have entered into a definitive merger agreement by which the companies will merge in an all-stock transaction, with BioSante as the surviving company. Under the terms of the merger agreement, Cell Genesys stockholders willhttp://nanotechwire.com/news.asp?nid=8151Cell Genesys IncorporatedWed, 01 Jul 2009 13:12:06 GMThttp://www.drugstorenews.com/story.aspx?id=108731BioSante Pharmaceuticals and Cell Genesys will merge in an all-stock transaction, the two companies have announced.http://www.drugstorenews.com/story.aspx?id=108731Cell Genesys IncorporatedTue, 30 Jun 2009 14:45:00 GMThttp://www.bizjournals.com/sanjose/stories/2009/06/29/daily31.htmlIn the first quarter, Cell Genesys lost $8.7 million, or 10 cents a share, narrowed from a loss in the same period last year of $22.6 million, or 29 cents a share.http://www.bizjournals.com/sanjose/stories/2009/06/29/daily31.htmlCell Genesys IncorporatedTue, 30 Jun 2009 14:42:33 GMThttp://www.foxbusiness.com/story/markets/industries/health-care/cell-genesys-merge-biosante/Cell Genesys To Merge With BioSantehttp://www.foxbusiness.com/story/markets/industries/health-care/cell-genesys-merge-biosante/Cell Genesys IncorporatedTue, 30 Jun 2009 12:23:00 GMThttp://www.marketwatch.com/story/cell-genesys-to-merge-with-biosante?siteid=rssBOSTON (MarketWatch) -- Cancer vaccine developer Cell Genesys said early Tuesday that it has signed a deal to be acquired by BioSante Pharmaceuticals in a transaction worth about 35 cents a share in BioSante stock. The deal, valued at about $38 million, represents a 12% premium over Cell Genesys'http://www.marketwatch.com/story/cell-genesys-to-merge-with-biosante?siteid=rssCell Genesys IncorporatedTue, 30 Jun 2009 12:23:47 GMThttp://www.genengnews.com/news/bnitem.aspx?name=57383910BioSante will outlicense other technologies, but transaction gives it cash for Phase III trials with female sexual dysfunction therapy.http://www.genengnews.com/news/bnitem.aspx?name=57383910Cell Genesys IncorporatedTue, 30 Jun 2009 00:00:00 GMThttp://www.pharmaceutical-business-review.com/news/biosante_cell_genesys_sign_merger_agreement_090630Merged company to focus on LibiGel, currently in Phase III clinical developmenthttp://www.pharmaceutical-business-review.com/news/biosante_cell_genesys_sign_merger_agreement_090630Cell Genesys IncorporatedTue, 30 Jun 2009 00:00:00 GMThttp://feeds.fool.com/~r/usmf/foolwatch/~3/FBRTMRmNa8E/worlds-scariest-stock-dendreon.aspxInvestors are a lot like a girl in a horror movie. The reason that the girl is screaming -- in my analogy, the reason investors are selling -- isn't because of what's outside her house. She's screaming because she doesn't know what's outside the house.http://feeds.fool.com/~r/usmf/foolwatch/~3/FBRTMRmNa8E/worlds-scariest-stock-dendreon.aspxCell Genesys IncorporatedFri, 31 Oct 2008 13:56:02 GMThttp://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2008/10/17/BUJE13IRCP.DTL&feed=rss.businessCell Genesys Inc., a 20-year-old Bay Area biotechnology company that has yet to win its first drug approval, said Thursday that it is firing most of its employees and considering a sale or merger after canceling work on its lead product. The South San...<ahttp://www.sfgate.com/cgi-bin/article.cgi?f=/c/a/2008/10/17/BUJE13IRCP.DTL&feed=rss.businessCell Genesys IncorporatedFri, 17 Oct 2008 07:00:00 GMThttp://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/081016/movers_roundup_kroger.html?.v=1Movers roundup: Kroger, Cell Genesys. - Among the stock activity stories for Thursday, Oct. 16, from AP Financial News:http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/ap/081016/movers_roundup_kroger.html?.v=1Cell Genesys IncorporatedThu, 16 Oct 2008 18:20:14 GMThttp://feeds.bizjournals.com/~r/vertical_36/~3/422823134/daily48.htmlCell Genesys Inc. shares dropped sharply today as the South San Francisco company said it will cut more than 200 jobs, is exploring its sale or liquidation, and stopping the late-stage trial of its prostate cancer drug.http://feeds.bizjournals.com/~r/vertical_36/~3/422823134/daily48.htmlCell Genesys IncorporatedThu, 16 Oct 2008 16:15:15 GMThttp://www.fool.com/investing/high-growth/2008/10/07/results-impact-volatility-at-dendreon.aspxThe Motley Fool - Dendreon almost hits both a 52-week high and a 52-week low on the day it releases results.http://www.fool.com/investing/high-growth/2008/10/07/results-impact-volatility-at-dendreon.aspxCell Genesys IncorporatedTue, 07 Oct 2008 16:18:32 GMThttp://www.newratings.com/en/main/company_headline.m?id=1799720NEW YORK, August 28 (newratings.com) - Analysts at Cantor Fitzgerald downgrade Cell Genesys (ticker: CEGE) from "buy" to "hold." The target price has been reduced from $10 to $2. [more]http://www.newratings.com/en/main/company_headline.m?id=1799720Cell Genesys IncorporatedThu, 28 Aug 2008 17:32:03 GMThttp://www.forbes.com/markets/economy/2008/08/27/cell-genesys-closer-markets-equity-cx_lal_0827markets35.htmlThe biopharma's shares tanked on bad news from its prostate cancer drug, but earlier data could turn that around.http://www.forbes.com/markets/economy/2008/08/27/cell-genesys-closer-markets-equity-cx_lal_0827markets35.htmlCell Genesys IncorporatedWed, 27 Aug 2008 22:22:38 GMThttp://online.wsj.com/article/SB121983964621676301.html?mod=googlenews_wsjCell Genesys ended its clinical trials for its prostate cancer treatment after seeing increased death rates compared with another regimen.http://online.wsj.com/article/SB121983964621676301.html?mod=googlenews_wsjCell Genesys IncorporatedWed, 27 Aug 2008 19:08:42 GMThttp://www.canadianbusiness.com/markets/headline_news/article.jsp?content=D929QKS80Biotech drug developer Cell Genesys Inc. reported Friday its loss widened in the second quarter, deshttp://www.canadianbusiness.com/markets/headline_news/article.jsp?content=D929QKS80Cell Genesys IncorporatedSat, 02 Aug 2008 01:26:00 GMThttp://www.californiabiotechlaw.com/archives/-biotech-deals-cell-genesys-closes-320-million-deal-with-takeda.htmlWhile investors may not aways support biotech alliances as discussed inour March 27thblog posting, entering into an alliance with ahttp://www.californiabiotechlaw.com/archives/-biotech-deals-cell-genesys-closes-320-million-deal-with-takeda.htmlCell Genesys IncorporatedThu, 03 Apr 2008 01:50:02 GMThttp://www.bloomberg.com/apps/news?pid=20601101&sid=aaOct5ZxIikU&refer=japanApril 1 (Bloomberg) -- Cell Genesys Inc. surged the most in almost a year in Nasdaq trading after it agreed to sell worldwide commercial rights for its experimental prostate cancer treatment to Takeda Pharmaceutical Co. The South San Francisco-based company jumped 74 cents, or 31 percent, to $3.http://www.bloomberg.com/apps/news?pid=20601101&sid=aaOct5ZxIikU&refer=japanCell Genesys IncorporatedTue, 01 Apr 2008 22:08:19 GMThttp://www.thestreet.com/_yahoo/newsanalysis/winners/10410239.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NAShares jump 29% after the company signs a new partner.. Check out TheStreet for the latest stock market news and financial investment headlines.http://www.thestreet.com/_yahoo/newsanalysis/winners/10410239.html?cm_ven=YAHOO&amp;cm_cat=FREE&amp;cm_ite=NACell Genesys IncorporatedTue, 01 Apr 2008 20:32:57 GMT